Managed Care Insights on the Advances in the Eosinophilic Esophagitis Treatment Landscape

This activity includes Pharmacy SoundScripts audio narration.

Program Description

Eosinophilic esophagitis (EoE) is a chronic inflammatory condition of the esophagus that can substantially impact patients' quality of life. Early diagnosis and intervention are critical for mitigating the clinical burden of EoE and improving long-term prognosis. This supplement to The American Journal of Managed Care® reviews recent advances in the treatment of EoE, focusing on the potential of recently approved therapies to improve patient outcomes. Data from recent clinical trials and updated guideline recommendations highlight the progress made in targeting the histology and symptomatology of the disease. Important managed care considerations, including financial challenges and treatment access issues, that arise from the introduction of these novel therapies will be examined. Pharmacists and managed care professionals will gain insights into the inflammatory process of EoE and the importance of early treatment while optimizing health care resource utilization. The article provides an analysis of clinical data to support the safe and effective use of new therapies, as well as potential opportunities for improving treatment decision-making and resource allocation in the management of EoE.

Target audience: Managed care pharmacists

Type of activity: Application
Release date: August 23, 2024
Expiration date: August 23, 2025

Time to complete activity: 1.0 hour

Learner level: Foundational, Intermediate
Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

• Examine the inflammatory process of eosinophilic esophagitis (EoE) and the value of early diagnosis and treatment to mitigate the clinical burden of disease.
• Analyze the clinical data and for the safe and appropriate use of new and emerging therapies that target the histology and symptomology of EoE.
• Investigate managed care interventions that promote timely and appropriate access to treatment and reduce health care resource utilization in the treatment of EoE.